Wolverine Trading
TMDX icon

Wolverine Trading’s Transmedics TMDX Stock Holding History

Wolverine Trading’s Portfolio TMDX Stock Details TMDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$8.57M Sell
76,100
-33,300
-30% -$3.9M 0.01% 1013
2025
Q2 		$14.4M Buy
109,400
+36,600
+50% +$4.02M 0.01% 566
2025
Q1 		$4.99M Buy
72,800
+16,200
+29% +$1.11M 0.01% 994
2024
Q4 		$3.36M Buy
56,600
+34,300
+154% +$3.19M ﹤0.01% 1502
2024
Q3 		$3.55M Buy
22,300
+5,500
+33% +$847K ﹤0.01% 1282
2024
Q2 		$2.53M Buy
16,800
+2,600
+18% +$312K ﹤0.01% 1427
2024
Q1 		$1.05M Sell
14,200
-100
-0.7% -$8.24K ﹤0.01% 2164
2023
Q4 		$1.13M Buy
14,300
+10,000
+233% +$603K ﹤0.01% 2197
2023
Q3 		$235K Buy
+4,300
New +$310K ﹤0.01% 3570
2021
Q4 		– Sell
-20,600
Closed -$655K – 6836
2021
Q3 		$655K Buy
20,600
+5,700
+38% +$174K ﹤0.01% 3564
2021
Q2 		$490K Buy
+14,900
New +$413K ﹤0.01% 3712

Other funds holding TMDX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Wolverine Trading's TMDX Position: Q3 2025 in Review

Wolverine Trading increased its Transmedics (TMDX) stake by 50% in Q3 2025, buying an estimated $2.57M and bringing the position to 65,578 shares worth $7.39M. The position accounts for 0.01% of the portfolio, ranked #1125.

Wolverine Trading first reported a position in TMDX in Q4 2021 and has held it in 9 quarters since. 388 funds tracked by Wall St. Rank hold TMDX as of Q3 2025.

  • Wolverine Trading held 65,578 shares of Transmedics worth $7.39M as of Q3 2025.
  • Wolverine Trading bought 21,985 Transmedics shares in Q3 2025, an estimated $2.57M.
  • Transmedics made up 0.01% of Wolverine Trading's portfolio in Q3 2025, its #1125 holding.
  • Wolverine Trading first reported a position in Transmedics in Q4 2021 and has held it in 9 quarters since.
  • 388 funds tracked by Wall St. Rank held Transmedics as of Q3 2025.

Based on Wolverine Trading's 13F filing for Q3 2025, filed 14 Nov 2025.